Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation - Opioid antagonist - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-01-30 10:26:50 Morphinans Phenols Alcohols Opioid receptor Opiates Kappa Opioid receptor Receptor antagonist Opioid Morphine Chemistry Neurochemistry Biochemistry		Kappa Opioid Receptor Agonists and Antagonist Summary: The present invention is an entirely new chemotype of KOR weak partial agonists. Contact Information: Matt Koenig, J.D. KU Innovation & Collaboration[removed]m Add to Reading List Source URL: kuic.ku.edu Download Document from Source Website File Size: 775,90 KB Share Document on Facebook

	INRC 2010 Program Sunday July 11, 00 RegistrationReception Monday July 12, 2010 DocID: 1g5dR - View Document
	Microsoft Word - PremioJRV2010.doc DocID: 1fs5f - View Document
	Checklist For Opioid Prescribing In Chronic Non-Cancer Pain A) COMPREHENSIVE ASSESSMENT “Bio-”: Underlying treatable condition (if possible) DocID: 11i3R - View Document
	A new target for alcoholism treatment: Kappa opioid receptors DocID: Yvjx - View Document
	CDC—Drug Overdose Prevention. DocID: T3AN - View Document